Bath & Body Works (NYSE:BBWI) Lowered to “Hold” Rating by Baird R W

Baird R W lowered shares of Bath & Body Works (NYSE:BBWI) from a strong-buy rating to a hold rating in a research report sent to investors on Friday morning,Zacks.com reports.

A number of other equities analysts also recently issued reports on BBWI. Citigroup lowered their price objective on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a research report on Friday. Robert W. Baird reissued a “neutral” rating and set a $19.00 target price (down previously from $33.00) on shares of Bath & Body Works in a research report on Thursday. Barclays lowered their price target on shares of Bath & Body Works from $28.00 to $18.00 and set an “equal weight” rating for the company in a report on Friday. The Goldman Sachs Group lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $39.00 to $17.00 in a research note on Thursday. Finally, Wells Fargo & Company lowered their target price on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday. Seven analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and a consensus target price of $26.90.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded down $0.98 during mid-day trading on Friday, reaching $14.84. 29,252,699 shares of the company’s stock were exchanged, compared to its average volume of 5,852,497. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $41.87. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of 4.40, a PEG ratio of 0.86 and a beta of 1.53. The business’s fifty day moving average price is $24.58 and its 200-day moving average price is $28.14.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business’s revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 5.4%. Bath & Body Works’s dividend payout ratio is currently 24.62%.

Institutional Trading of Bath & Body Works

Large investors have recently made changes to their positions in the company. Danske Bank A S bought a new stake in Bath & Body Works in the 3rd quarter valued at about $39,000. Advisory Services Network LLC bought a new stake in shares of Bath & Body Works during the third quarter valued at approximately $48,000. Dark Forest Capital Management LP raised its position in shares of Bath & Body Works by 91.3% during the third quarter. Dark Forest Capital Management LP now owns 101,662 shares of the company’s stock worth $2,619,000 after purchasing an additional 48,525 shares during the period. XTX Topco Ltd bought a new position in shares of Bath & Body Works in the 3rd quarter worth $1,256,000. Finally, United Capital Financial Advisors LLC acquired a new stake in Bath & Body Works in the 3rd quarter valued at $263,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.